Ubs Group Ag Hillstream Bio Pharma Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.19 - $0.42 $8,327 - $18,408	43,829 New	43,829 $8,000
Q1 2023 May 12, 2023	SELL	$0.34 - $1.89 $3,214 - $17,866	-9,453 Reduced 82.65%	1,984 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.32 - $0.61 $224 - $428	702 Added 6.54%	11,437 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.78 - $1.48 $8,373 - $15,887	10,735 New	10,735 $9,000

Ticker HILS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,529,900
Market Cap $33.2M
Description
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.